Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    January 2022
  1. PATEL A, Tillman BF
    Spur-Cell Hemolytic Anemia.
    N Engl J Med. 2022;386:e6.
    PubMed    


  2. SANYAL AJ, Van Natta ML, Tonascia J
    Nonalcoholic Fatty Liver Disease. Reply.
    N Engl J Med. 2022;386:296.
    PubMed    


  3. FRANCQUE SM, Bedossa P, Abdelmalek MF
    Nonalcoholic Fatty Liver Disease. Reply.
    N Engl J Med. 2022;386:295-296.
    PubMed    


  4. MIR BA, Majeed T, Chauhan A
    Nonalcoholic Fatty Liver Disease.
    N Engl J Med. 2022;386:295.
    PubMed    


  5. XIA ML, Wang H
    Nonalcoholic Fatty Liver Disease.
    N Engl J Med. 2022;386:294-295.
    PubMed    


  6. HORN P, Newsome PN
    Nonalcoholic Fatty Liver Disease.
    N Engl J Med. 2022;386:294.
    PubMed    


    December 2021
  7. WILLETT LL, Bromberg GK, Chung R, Leaf RK, et al
    Case 38-2021: A 76-Year-Old Woman with Abdominal Pain, Weight Loss, and Memory Impairment.
    N Engl J Med. 2021;385:2378-2388.
    PubMed    


    November 2021
  8. CHAPMAN MM, Muse VV, Mojica JE, Anahtar MN, et al
    Case 35-2021: A 50-Year-Old Woman with Pain in the Left Upper Quadrant and Hypoxemia.
    N Engl J Med. 2021;385:1995-2001.
    PubMed    


    October 2021
  9. GARCIA-TSAO G
    Nonalcoholic Steatohepatitis - Opportunities and Challenges.
    N Engl J Med. 2021;385:1615-1617.
    PubMed    


  10. SANYAL AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, et al
    Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
    N Engl J Med. 2021;385:1559-1569.
    PubMed     Abstract available


  11. FRANCQUE SM, Bedossa P, Ratziu V, Anstee QM, et al
    A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
    N Engl J Med. 2021;385:1547-1558.
    PubMed     Abstract available


    September 2021
  12. CHANDRA A, Bhattacharjee MS
    Kayser-Fleischer Rings in Wilson's Disease.
    N Engl J Med. 2021;385:e46.
    PubMed    


  13. BAJAJ JS, Kamath PS, Reddy KR
    The Evolving Challenge of Infections in Cirrhosis. Reply.
    N Engl J Med. 2021;385:1151-1152.
    PubMed    


  14. HAIDAR G, Singh N
    The Evolving Challenge of Infections in Cirrhosis.
    N Engl J Med. 2021;385:1150-1151.
    PubMed    


    August 2021
  15. ZOU Q, Li Y
    Hypervirulent Klebsiella pneumoniae.
    N Engl J Med. 2021;385:833.
    PubMed    


  16. FREDRICK TW, Neto MBB, Johnsrud DO, Camilleri M, et al
    Turning Purple with Pain.
    N Engl J Med. 2021;385:549-554.
    PubMed    


    July 2021
  17. KELLEY RK, Greten TF
    Hepatocellular Carcinoma - Origins and Outcomes.
    N Engl J Med. 2021;385:280-282.
    PubMed    


  18. BUTTERS CT, Nash M
    Infantile Hepatic Hemangiomas.
    N Engl J Med. 2021;385:e10.
    PubMed    


  19. NEWSOME PN, Sejling AS, Sanyal AJ
    Semaglutide or Placebo for Nonalcoholic Steatohepatitis. Reply.
    N Engl J Med. 2021;385:e6.
    PubMed    


  20. DA BL, Satapathy SK
    Semaglutide or Placebo for Nonalcoholic Steatohepatitis.
    N Engl J Med. 2021;385:e6.
    PubMed    


    June 2021
  21. BAJAJ JS, Kamath PS, Reddy KR
    The Evolving Challenge of Infections in Cirrhosis.
    N Engl J Med. 2021;384:2317-2330.
    PubMed    


  22. WONG F, Curry MP, Sanyal AJ
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
    N Engl J Med. 2021;384:e90.
    PubMed    


  23. CHINA L, Freemantle N, O'Brien A
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
    N Engl J Med. 2021;384:e90.
    PubMed    


  24. RATHI S, Kalantri A, Kalantri S
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed    


  25. CHAUHAN A, Sharma S, Saraya A
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed    


  26. ELFEKI MA, O'Shea R, Carey WD
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed    


    April 2021
  27. COHN A, Nehs M, Chan J, Vaidya A, et al
    Casting a Wide Net.
    N Engl J Med. 2021;384:e50.
    PubMed    


  28. MCINNES IB, Anderson JK, Magrey M, Merola JF, et al
    Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.
    N Engl J Med. 2021;384:1227-1239.
    PubMed     Abstract available


    March 2021
  29. GOYAL L, Chen CT, Pierce TT, Deshpande V, et al
    Case 8-2021: A 34-Year-Old Woman with Cholangiocarcinoma.
    N Engl J Med. 2021;384:1054-1064.
    PubMed    


  30. GARCIA-TSAO G
    Terlipressin and Intravenous Albumin in Advanced Cirrhosis - Friend and Foe.
    N Engl J Med. 2021;384:869-871.
    PubMed    


  31. WONG F, Pappas SC, Curry MP, Reddy KR, et al
    Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
    N Engl J Med. 2021;384:818-828.
    PubMed     Abstract available


  32. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:808-817.
    PubMed     Abstract available


    November 2020
  33. NEWSOME PN, Buchholtz K, Cusi K, Linder M, et al
    A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2028395.
    PubMed     Abstract available


  34. BALWANI M, Sardh E, Gouya L
    Givosiran for Acute Intermittent Porphyria. Reply.
    N Engl J Med. 2020;383:1989-1990.
    PubMed    


  35. GOMA-GARCES E, Perez-Gomez MV, Ortiz A
    Givosiran for Acute Intermittent Porphyria.
    N Engl J Med. 2020;383:1989.
    PubMed    


    August 2020
  36. JALAN R, Moreau R, Arroyo V
    Acute-on-Chronic Liver Failure. Reply.
    N Engl J Med. 2020;383:893-894.
    PubMed    


  37. PERRICONE G, Mancuso A, Belli LS
    Acute-on-Chronic Liver Failure.
    N Engl J Med. 2020;383:893.
    PubMed    


  38. KUMAR K, Kulkarni A
    Acute-on-Chronic Liver Failure.
    N Engl J Med. 2020;383:892-893.
    PubMed    


  39. JINDAL A
    Acute-on-Chronic Liver Failure.
    N Engl J Med. 2020;383:892.
    PubMed    


  40. FINN RS, Cheng AL
    Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply.
    N Engl J Med. 2020;383:695.
    PubMed    


  41. TARANTINO P, Curigliano G
    Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.
    N Engl J Med. 2020;383:694-695.
    PubMed    


  42. HIZAL M, Sendur MAN, Yalcin B
    Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.
    N Engl J Med. 2020;383:694.
    PubMed    


  43. BOMZE D, Meirson T, Azoulay D
    Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.
    N Engl J Med. 2020;383:693-694.
    PubMed    


    July 2020
  44. SHEHADEH M, Oweis E
    Silver Stool.
    N Engl J Med. 2020;383:261.
    PubMed    


    June 2020
  45. SIMON TG, Ludvigsson JF
    Association between Aspirin and Hepatocellular Carcinoma. Reply.
    N Engl J Med. 2020;382:2481-2482.
    PubMed    


  46. CAREY W, Romero-Marrero C
    Association between Aspirin and Hepatocellular Carcinoma.
    N Engl J Med. 2020;382:2481.
    PubMed    


  47. LIAO R, Zhou BY, Wu ZJ
    Association between Aspirin and Hepatocellular Carcinoma.
    N Engl J Med. 2020;382:2480-2481.
    PubMed    


  48. GONZALEZ-ASEGUINOLAZA G
    Givosiran - Running RNA Interference to Fight Porphyria Attacks.
    N Engl J Med. 2020;382:2366-2367.
    PubMed    


  49. BALWANI M, Sardh E, Ventura P, Peiro PA, et al
    Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
    N Engl J Med. 2020;382:2289-2301.
    PubMed     Abstract available


    May 2020
  50. ARROYO V, Moreau R, Jalan R
    Acute-on-Chronic Liver Failure.
    N Engl J Med. 2020;382:2137-2145.
    PubMed    


  51. FINN RS, Qin S, Ikeda M, Galle PR, et al
    Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
    N Engl J Med. 2020;382:1894-1905.
    PubMed     Abstract available


  52. KELLEY RK
    Atezolizumab plus Bevacizumab - A Landmark in Liver Cancer.
    N Engl J Med. 2020;382:1953-1955.
    PubMed    


  53. MICIC D, Oto A, Charlton MR, Benoit JL, et al
    Hiding in the Water.
    N Engl J Med. 2020;382:1844-1849.
    PubMed    


    April 2020
  54. MCELVANEY OJ, Carroll TP, Franciosi AN, Sweeney J, et al
    Consequences of Abrupt Cessation of Alpha1-Antitrypsin Replacement Therapy.
    N Engl J Med. 2020;382:1478-1480.
    PubMed    


  55. STRNAD P, McElvaney NG, Lomas DA
    Alpha1-Antitrypsin Deficiency.
    N Engl J Med. 2020;382:1443-1455.
    PubMed    


  56. LAU JYW, Yu Y, Tang RSY, Chan HCH, et al
    Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding.
    N Engl J Med. 2020;382:1299-1308.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: